Literature DB >> 2253667

Effect of ponsinomycin on cyclosporin pharmacokinetics.

W Couet1, B Istin, P Seniuta, D Morel, L Potaux, J B Fourtillan.   

Abstract

The influence of treatment with ponsinomycin, a new macrolide antibiotic, on the pharmacokinetics of cyclosporin A has been studied in 10 renal transplant patients. The pharmacokinetics of cyclosporin A was investigated at steady state, before and during treatment with ponsinomycin. On average, the blood levels of cyclosporin A were doubled by the macrolide, possibly due to a decrease in elimination or/and to an increase in absorption. Ponsinomycin should be use very carefully in patients treated with cyclosporin A.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253667     DOI: 10.1007/bf00280052

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  Effect of ponsinomycin on single-dose kinetics and metabolism of carbamazepine.

Authors:  W Couet; B Istin; I Ingrand; J Girault; J B Fourtillan
Journal:  Ther Drug Monit       Date:  1990-03       Impact factor: 3.681

2.  Studies of cyclosporine blood levels: analysis, clinical utility, pharmacokinetics, metabolites, and chronopharmacology.

Authors:  L D Bowers; D M Canafax; J Singh; R Seifedlin; R L Simmons; J S Najarian
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

3.  Interaction between cyclosporin and erythromycin in a kidney transplant patient.

Authors:  M Kessler; J Louis; E Renoult; B Vigneron; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Effect of josamycin on plasma cyclosporine levels.

Authors:  C Kreft-Jais; E M Billaud; C Gaudry; J Bedrossian
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Clinically important interaction of cyclosporine and erythromycin.

Authors:  B M Murray; L Edwards; G D Morse; R R Kohli; R C Venuto
Journal:  Transplantation       Date:  1987-04       Impact factor: 4.939

Review 6.  Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters.

Authors:  B D Kahan
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

Review 7.  Cyclosporine drug interactions: a review.

Authors:  N K Wadhwa; T J Schroeder; A J Pesce; S A Myre; C W Clardy; M R First
Journal:  Ther Drug Monit       Date:  1987-12       Impact factor: 3.681

8.  Effect of erythromycin on cyclosporine levels.

Authors:  R J Ptachcinski; B J Carpenter; G J Burckart; R Venkataramanan; J T Rosenthal
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

9.  Liquid-chromatographic determination of cyclosporin A in blood and plasma.

Authors:  R J Sawchuk; L L Cartier
Journal:  Clin Chem       Date:  1981-08       Impact factor: 8.327

10.  Cyclosporin-erythromycin interaction in renal transplant patients.

Authors:  S K Gupta; A Bakran; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

View more
  4 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 2.  Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

Authors:  S M Holliday; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 3.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

Review 4.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.